These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 15282454)

  • 1. Hirudin ameliorates intestinal radiation toxicity in the rat: support for thrombin inhibition as strategy to minimize side-effects after radiation therapy and as countermeasure against radiation exposure.
    Wang J; Zheng H; Ou X; Albertson CM; Fink LM; Herbert JM; Hauer-Jensen M
    J Thromb Haemost; 2004 Nov; 2(11):2027-35. PubMed ID: 15550035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of secondary microthrombosis after thrombin-induced stroke in mice and non-human primates.
    Gauberti M; Martinez de Lizarrondo S; Orset C; Vivien D
    J Thromb Haemost; 2014; 12(3):409-14. PubMed ID: 24354644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular dysfunction following cardiopulmonary bypass plays a central role in postoperative organ dysfunction.
    Kant S; Banerjee D; Sabe SA; Sellke F; Feng J
    Front Med (Lausanne); 2023; 10():1110532. PubMed ID: 36865056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction to "The effects of recombinant human granulocyte-colonystimulating factor on vascular dysfunction and splanchnicischaemia-reperfusion injury".
    Br J Pharmacol; 2023 Oct; 180(20):2694. PubMed ID: 37593955
    [No Abstract]   [Full Text] [Related]  

  • 5. Traditional Chinese Medicine for Coronary Heart Disease: Clinical Evidence and Possible Mechanisms.
    Zhang KJ; Zheng Q; Zhu PC; Tong Q; Zhuang Z; Zhu JZ; Bao XY; Huang YY; Zheng GQ; Wang Y
    Front Pharmacol; 2019; 10():844. PubMed ID: 31427964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant therapy during cardiopulmonary bypass.
    Yavari M; Becker RC
    J Thromb Thrombolysis; 2008 Dec; 26(3):218-28. PubMed ID: 18931979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin deficiency in special clinical syndromes--Part II: cardiovascular surgery.
    Levy JH
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):49-55. PubMed ID: 8821210
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of thrombin during reperfusion improves immediate postischemic myocardial function and modulates apoptosis in a porcine model of cardiopulmonary bypass.
    Jormalainen M; Vento AE; Lukkarinen H; Kääpä P; Kytö V; Lauronen J; Paavonen T; Suojaranta-Ylinen R; Petäjä J
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):224-31. PubMed ID: 17418736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin reduces pulmonary hypertension during reperfusion after cardiopulmonary bypass in a pig.
    Jormalainen M; Vento AE; Wartiovaara-Kautto U; Suojaranta-Ylinen R; Lauronen J; Paavonen T; Petäjä J
    Acta Anaesthesiol Scand; 2007 Feb; 51(2):178-88. PubMed ID: 17096669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated protein C in the cardioplegic solution on a porcine model of coronary ischemia-reperfusion has deleterious hemodynamic effects.
    Fernández JA; Vento AE; Jormalainen M; Griffin JH; Pesonen E; Syrjälä M; Repo H; Jansson SE; Rämö OJ; Petäjä J
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):113-21. PubMed ID: 16761191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons.
    van Wyk V; Neethling WM; Badenhorst PN; Kotzé HF
    J Cardiovasc Surg (Torino); 1998 Oct; 39(5):633-9. PubMed ID: 9833724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant hirudin enhances cardiac output and decreases systemic vascular resistance during reperfusion after cardiopulmonary bypass in a porcine model.
    Jormalainen M; Vento AE; Wartiovaara-Kautto U; Suojaranta-Ylinen R; Rämö OJ; Petäjä J
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):189-96. PubMed ID: 15282454
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.